Abstract. Forty-two patients with visceral leishmaniasis in Tunisia were treated with meglumine antimoniate and followed-up for clinical improvement and blood parasite load determined by quantitative real-time polymerase chain reaction (PCR). Parasite loads before treatment ranged from 27 to 5.3 × 10 7 parasites/mL. At the end of treatment, parasite load decreased significantly in 39 cured patients ( P < 0.001). The decrease in parasite load after treatment was greater than 99 % for 34 patients and PCR results became negative in 23 of them. Two patients without clinical improve-ment showed no or slight decreases in parasite load (209 versus 202 parasites/mL and 1,765 versus 146 parasites/mL). One patient showed had a relapse seven months...
ABSTRACT Leishmania donovani is an intracellular protozoan parasite that causes leishmaniasis, which...
<p>(A, C and E) Dose response for pentoxifylline alone, combined with 8 μg Sb<sup>V</sup>/ml meglumi...
Abstract INTRODUCTION: Favorable responses in American tegumentary leishmaniasis (ATL) patients to ...
The available treatment options for visceral leishmaniasis (VL) have problems relating to efficacy, ...
In a pilot trial, 28 days of oral treatment with 100-200 mg miltefosine (hexadecylphosphocholine) pe...
Abstract- Visceral leishmaniasis (VL) is usually treated with pentavalent antimonial drugs given alo...
ABSTRACT Leishmania donovani is an intracellular protozoan parasite that causes leishmaniasis, which...
Background: To expedite the development of new oral treatment regimens for visceral leishmaniasis (V...
Introduction: Visceral leishmaniasis is an endemic protozoan found in Brazil. It is characterized by...
Visceral leishmaniasis (VL) is usually treated with pentavalent antimonial drugs given alone or in c...
Abstract INTRODUCTION: The treatment of mucosal leishmaniasis (ML) is difficult due to the toxicit...
The treatment of visceral leishmaniasis (VL) is poorly standardized in Italy in spite of the existin...
Sixty-six Guatemalan men with parasitologically confirmed cutaneous leishmaniasis, due most commonly...
In a comparative trial of treatment in southern Sudan, visceral leishmaniasis was diagnosed by the f...
Leishmaniasis, in its variety of visceral (VL), cutaneous (CL) and mucocutaneous (MCL) forms, direct...
ABSTRACT Leishmania donovani is an intracellular protozoan parasite that causes leishmaniasis, which...
<p>(A, C and E) Dose response for pentoxifylline alone, combined with 8 μg Sb<sup>V</sup>/ml meglumi...
Abstract INTRODUCTION: Favorable responses in American tegumentary leishmaniasis (ATL) patients to ...
The available treatment options for visceral leishmaniasis (VL) have problems relating to efficacy, ...
In a pilot trial, 28 days of oral treatment with 100-200 mg miltefosine (hexadecylphosphocholine) pe...
Abstract- Visceral leishmaniasis (VL) is usually treated with pentavalent antimonial drugs given alo...
ABSTRACT Leishmania donovani is an intracellular protozoan parasite that causes leishmaniasis, which...
Background: To expedite the development of new oral treatment regimens for visceral leishmaniasis (V...
Introduction: Visceral leishmaniasis is an endemic protozoan found in Brazil. It is characterized by...
Visceral leishmaniasis (VL) is usually treated with pentavalent antimonial drugs given alone or in c...
Abstract INTRODUCTION: The treatment of mucosal leishmaniasis (ML) is difficult due to the toxicit...
The treatment of visceral leishmaniasis (VL) is poorly standardized in Italy in spite of the existin...
Sixty-six Guatemalan men with parasitologically confirmed cutaneous leishmaniasis, due most commonly...
In a comparative trial of treatment in southern Sudan, visceral leishmaniasis was diagnosed by the f...
Leishmaniasis, in its variety of visceral (VL), cutaneous (CL) and mucocutaneous (MCL) forms, direct...
ABSTRACT Leishmania donovani is an intracellular protozoan parasite that causes leishmaniasis, which...
<p>(A, C and E) Dose response for pentoxifylline alone, combined with 8 μg Sb<sup>V</sup>/ml meglumi...
Abstract INTRODUCTION: Favorable responses in American tegumentary leishmaniasis (ATL) patients to ...